ClinicalTrials.govpublic full text
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
locally advanced non-small cell lung cancer (nsclc), thoracic radiotherapy, immune checkpoint inhibitors, neoadjuvant chemoimmunotherapy, spatially fractionated radiotherapy, locally advanced nsclc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892549
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.